The estimated net worth of Dr. Richard S. Geary is at least $24,832,158 as of 29 Aug 2024. He owns shares worth
$3,603,281 as insider, has earned $7,326,317
from insider trading and has received compensation worth at least
$13,902,560 in Ionis Pharmaceuticals, Inc..
What is the salary of Richard S. Geary?
Dr. Richard S. Geary salary is $868,910 per year
as Executive Vice President & Chief Devel. Officer in Ionis Pharmaceuticals, Inc..
How old is Richard S. Geary?
Dr. Richard S. Geary is 67 years old, born in 1958.
What stocks does Richard S. Geary currently own?
As insider, Dr. Richard S. Geary owns shares in one company:
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
Dr. Richard S. Geary has made 57 insider trades between 2009-2024, according to the Form 4 filled with the SEC. Most recently he sold
331 units of IONS stock worth $16,428 on 29 Aug 2024.
The largest trade he's
ever made was exercising 46,240 units of IONS stock
on 8 Apr 2019. As of 29 Aug 2024
he still owns at least 84,823 units of IONS stock.